Vanberra Signal

Insilico Medicine

Curated by Signal

AI driven age prediction tool

Overview

Insilico Medicine is using artificial intelligence to develop biomarkers of human aging and health status. The company's product, called Aging.AI claims to be a deep-learned predictor of age that has been trained on hundreds of thousands of anonymized human blood tests. One can provide blood test results along with weight, height, and smoking status for the system to calculate his or her age. The company intends to leverage the system to test effects of lifestyle interventions such as diet or exercise on the status of health and age-related markers. The company collaborates with the Biogerontology Research Foundation to develop its biomarker programs.

Key facts

Founded
2014
Headquarters
Berlin, Germany

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of a bioinformatics platform for multi-omics data analysis

    Life Sciences TechnologyHamburg, Germany
  • Provider of AI-based real-time diagnostics devices for SARS-CoV-2 testing

    Life Sciences TechnologyMainz, Germany
  • Developer of material handling robots for laboratory applications

    Life Sciences TechnologyKonstanz, Germany

About Insilico Medicine

What does Insilico Medicine do?

Insilico Medicine is using artificial intelligence to develop biomarkers of human aging and health status.

Where is Insilico Medicine headquartered?

Insilico Medicine is headquartered in Berlin, Germany.

When was Insilico Medicine founded?

Insilico Medicine was founded in 2014.

Which sector is Insilico Medicine in?

Insilico Medicine operates in Life Sciences Technology.

Who are Insilico Medicine's competitors?

Companies similar to Insilico Medicine include cropSeq bioinformatics, Digital Diagnostics, and I-Gripper.